Atlas Trials

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Clinical trial NCT01811160 · COMPLETED

Trial details

NCT number
NCT01811160
Sponsor
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Start date
2008-10-01
Primary completion
2011-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.